These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 2901903)
1. Effect of dopaminergic and alpha-adrenergic modulation on corticotropin-releasing factor immunoreactivity in rat hypothalamus. Haas DA; George SR Can J Physiol Pharmacol; 1988 Jun; 66(6):754-61. PubMed ID: 2901903 [TBL] [Abstract][Full Text] [Related]
2. Differential alpha-1 and alpha-2 adrenergic effects on hypothalamic corticotropin-releasing factor and plasma adrenocorticotropin. Haas DA; Sturtridge WC; George SR Neuroscience; 1990; 38(3):693-701. PubMed ID: 1980144 [TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y-induced effects on hypothalamic corticotropin-releasing factor content and release are dependent on noradrenergic/adrenergic neurotransmission. Haas DA; George SR Brain Res; 1989 Oct; 498(2):333-8. PubMed ID: 2551461 [TBL] [Abstract][Full Text] [Related]
4. The corticotropin-releasing factor release in rat hypophysial portal blood is mediated by brain catecholamines. Guillaume V; Conte-Devolx B; Szafarczyk A; Malaval F; Pares-Herbute N; Grino M; Alonso G; Assenmacher I; Oliver C Neuroendocrinology; 1987 Aug; 46(2):143-6. PubMed ID: 2819759 [TBL] [Abstract][Full Text] [Related]
5. Adrenergic regulation of hypothalamic proenkephalin neurons: evidence for opposite effects in subpopulations terminating in median eminence and neurointermediate pituitary. George SR; Roldan L; Haas DA Neuroendocrinology; 1990 Aug; 52(2):191-5. PubMed ID: 2125707 [TBL] [Abstract][Full Text] [Related]
6. Time course study on the effect of reserpine on hypothalamic immunoreactive CRF levels in rats. Suda T; Tomori N; Yajima F; Sumitomo T; Nakagami Y; Ushiyama T; Demura H; Shizume K Brain Res; 1987 Mar; 405(2):247-52. PubMed ID: 3032352 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of norepinephrine on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro. Suda T; Yajima F; Tomori N; Sumitomo T; Nakagami Y; Ushiyama T; Demura H; Shizume K Life Sci; 1987 Apr; 40(17):1645-9. PubMed ID: 2882402 [TBL] [Abstract][Full Text] [Related]
8. Norepinephrine but not epinephrine stimulates the release of corticotropin-releasing factor from in vitro superfused rat hypothalamus. Orliaguet G; Mélik Parsadaniantz S; Lenoir V; Duval P; Kerdelhué B J Neurosci Res; 1995 Oct; 42(2):236-41. PubMed ID: 8568924 [TBL] [Abstract][Full Text] [Related]
10. Gonadal regulation of corticotropin-releasing factor immunoreactivity in hypothalamus. Haas DA; George SR Brain Res Bull; 1988 Mar; 20(3):361-7. PubMed ID: 3284608 [TBL] [Abstract][Full Text] [Related]
11. Lack of effect of corticotropin releasing factor on hypothalamic dopamine and serotonin synthesis turnover rates in rats. Van Loon GR; Shum A; Ho D Peptides; 1982; 3(5):799-803. PubMed ID: 6294636 [TBL] [Abstract][Full Text] [Related]
12. Hypothalamic corticotropin-releasing factor immunoreactivity is reduced during induction of pituitary tumors by chronic estrogen treatment. Haas DA; Borgundvaag B; Sturtridge WC; George SR Life Sci; 1987 Nov; 41(18):2101-6. PubMed ID: 3499556 [TBL] [Abstract][Full Text] [Related]
13. Effect of hypothalamic norepinephrine depletion on median eminence CRF-41 content and serum ACTH in control and adrenalectomized rats. Weidenfeld J; Feldman S Brain Res; 1991 Mar; 542(2):201-4. PubMed ID: 1851452 [TBL] [Abstract][Full Text] [Related]
14. Increase of corticotropin-releasing factor staining in rat paraventricular nucleus neurones by depletion of hypothalamic adrenaline. Mezey E; Kiss JZ; Skirboll LR; Goldstein M; Axelrod J Nature; 1984 Jul 12-18; 310(5973):140-1. PubMed ID: 6377089 [TBL] [Abstract][Full Text] [Related]
15. The adrenocorticotropin response to interleukin-1 beta instilled into the rat median eminence depends on the local release of catecholamines. Matta S; Singh J; Newton R; Sharp BM Endocrinology; 1990 Nov; 127(5):2175-82. PubMed ID: 2171909 [TBL] [Abstract][Full Text] [Related]
16. Relationship of alpha-1- and alpha-2-adrenergic-binding sites to regions of the paraventricular nucleus of the hypothalamus containing corticotropin-releasing factor and vasopressin neurons. Cummings S; Seybold V Neuroendocrinology; 1988 Jun; 47(6):523-32. PubMed ID: 2899848 [TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing factor release from in vitro superfused and incubated rat hypothalamus. Effect of potassium, norepinephrine, and dopamine. Joanny P; Steinberg J; Zamora AJ; Conte-Devolx B; Millet Y; Oliver C Peptides; 1989; 10(5):903-11. PubMed ID: 2514417 [TBL] [Abstract][Full Text] [Related]
18. Regulation of intermediate pituitary corticotropin-releasing hormone receptors by dopamine. Shiver T; Familari M; Aguilera G Endocrinology; 1992 Apr; 130(4):2299-304. PubMed ID: 1347742 [TBL] [Abstract][Full Text] [Related]